The HER2, E-Cad, Ki67, Molecular subtypes and lymph node metastasis of the metastasis group was higher than that of the control group (metastasis-free group) (P < 0.10). The gene discussed is ERBB2; the disease is metastatic malignant neoplasm in the lymph nodes.